Connection
Wells Messersmith to Lymphopenia
This is a "connection" page, showing publications Wells Messersmith has written about Lymphopenia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.025 |
|
|
|
-
Ma WW, Messersmith WA, Dy GK, Weekes CD, Whitworth A, Ren C, Maniar M, Wilhelm F, Eckhardt SG, Adjei AA, Jimeno A. Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer. Clin Cancer Res. 2012 Apr 01; 18(7):2048-55.
Score: 0.025